Editas Medicine, Inc.
Viés de alta

EDIT - another genomics name that looks ready

269
All major gene editing stocks look like they're on the cusp of big moves higher. (See last post on NTLA)
NTLA - trend continuation likely


Zoomed in on the shorter time frame we have a trigger off the 618 4hr retrace. There's some overhead supply in the 50s for shorter term targets, but this is a long term play with much higher upside.
snapshot

Seeing similar in CRSP, but EDIT is showing a more significant breakout on the monthly time frame
Short term quick look at CRSP:
snapshot

NTLA is the leader in the sector right now, but that could change fast. I am long all three

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.